| Date | Time | Source | Announcement |
|---|---|---|---|
| 02 Nov 2023 | 07:00 AM | 3rd Quarter 2023 Trading Report | |
| 01 Nov 2023 | 04:36 PM | Total Voting Rights | |
| 01 Nov 2023 | 10:09 AM | MEET THE MANAGEMENT EVENT | |
| 20 Oct 2023 | 10:34 AM | STERLING AMOUNT OF DIVIDEND | |
| 13 Oct 2023 | 08:58 AM | Notice of Results | |
| 02 Oct 2023 | 04:29 PM | Total Voting Rights | |
| 14 Sep 2023 | 07:00 AM | Board Changes | |
| 01 Sep 2023 | 03:47 PM | Total Voting Rights | |
| 23 Aug 2023 | 03:41 PM | Director/PDMR Shareholding | |
| 15 Aug 2023 | 11:59 AM | Director/PDMR Shareholding | |
| 14 Aug 2023 | 02:27 PM | Director/PDMR Shareholding | |
| 07 Aug 2023 | 10:51 AM | Block listing Interim Review | |
| 03 Aug 2023 | 07:02 AM | Directorate Change | |
| 03 Aug 2023 | 07:00 AM | Half-year Report | |
| 01 Aug 2023 | 12:37 PM | Total Voting Rights | |
| 21 Jul 2023 | 01:45 PM | Director/PDMR Shareholding | |
| 06 Jul 2023 | 07:00 AM | Notice of Results | |
| 03 Jul 2023 | 04:07 PM | Total Voting Rights | |
| 30 Jun 2023 | 10:21 AM | Director Declaration | |
| 01 Jun 2023 | 12:30 PM | Total Voting Rights | |
| 24 May 2023 | 04:45 PM | Director/PDMR Shareholding | |
| 19 May 2023 | 04:15 PM | Director/PDMR Shareholding | |
| 05 May 2023 | 07:08 AM | Dividend Declaration | |
| 05 May 2023 | 07:00 AM | Director Declaration | |
| 03 May 2023 | 09:30 AM | Director/PDMR Shareholding | |
| 02 May 2023 | 01:53 PM | Total Voting Rights | |
| 27 Apr 2023 | 03:25 PM | Director/PDMR Shareholding | |
| 26 Apr 2023 | 03:36 PM | Result of AGM | |
| 26 Apr 2023 | 07:00 AM | Q1 2023 Trading Update | |
| 06 Apr 2023 | 07:00 AM | Notice of First Quarter 2023 Trading Report | |
| 03 Apr 2023 | 02:07 PM | Total Voting Rights | |
| 13 Mar 2023 | 01:45 PM | Director/PDMR Shareholding | |
| 06 Mar 2023 | 06:00 PM | Annual Financial Report | |
| 01 Mar 2023 | 02:44 PM | Total Voting Rights | |
| 22 Feb 2023 | 01:07 PM | Director/PDMR Shareholding | |
| 21 Feb 2023 | 01:41 PM | Director/PDMR Shareholding | |
| 21 Feb 2023 | 07:00 AM | Final Results | |
| 17 Feb 2023 | 07:00 AM | Directorate Change | |
| 01 Feb 2023 | 04:15 PM | Block listing Interim Review | |
| 01 Feb 2023 | 11:20 AM | Total Voting Rights | |
| 26 Jan 2023 | 12:22 PM | Notice of Results | |
| 19 Jan 2023 | 03:19 PM | Director/PDMR Shareholding | |
| 03 Jan 2023 | 01:47 PM | Total Voting Rights | |
| 12 Dec 2022 | 04:37 PM | Director/PDMR Shareholding | |
| 09 Dec 2022 | 11:30 AM | Director/PDMR Shareholding | |
| 01 Dec 2022 | 02:00 PM | Total Voting Rights | |
| 16 Nov 2022 | 11:30 AM | Director/PDMR Shareholding | |
| 10 Nov 2022 | 07:00 AM | Director/PDMR Shareholding | |
| 03 Nov 2022 | 07:00 AM | 3rd Quarter 2022 Trading Report | |
| 01 Nov 2022 | 10:38 AM | Total Voting Rights |
Smith & Nephew is a British medical technology company that develops, manufactures, and sells medical devices. Products include arthroscopy, trauma, clinical therapy, and orthopaedic reconstruction products. Smith & Nephew's products are sold in over 100 countries, including Europe, the Americas, Asia Pacific, the Middle East, and Africa.
Smith & Nephew operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management.
Smith & Nephew's shares are traded in London and New York, and the company is a constituent of the UK's FTSE100.
Smith and Nephew share price launched at 182p in 1988.